Angiosarcoma arising in the capsule of a mammary silicone implant

Sreekumar Sundara Rajan1, Asma Haider2, Helen Burrell1

  • 1Breast Institute, Nottingham University Hospitals, Nottingham, UK.

Diagnostic Cytopathology
|January 7, 2022
PubMed

Insights

A rare angiosarcoma was diagnosed in fluid around a silicone breast implant. This highlights the importance of fluid cytology for detecting implant-associated cancers.

Area of Science:

  • Oncology
  • Pathology
  • Radiology

Background:

  • Silicone breast implants are widely used for augmentation and reconstruction.
  • Complications can arise, including rare malignancies.
  • Early detection of implant-associated complications is crucial.

Observation:

  • A 40-year-old woman presented with painful swelling and bruising of the breast with silicone implants.
  • Ultrasound revealed periprosthetic fluid; cytology showed atypical cells.
  • MRI demonstrated a serpiginous enhancing area within the fibrous capsule.

Findings:

  • Histology confirmed angiosarcoma invading the fibrous capsule and periprosthetic space.
  • Tumor markers CD31 and CD34 were positive in spindle cells.
  • The tumor location mirrored that of breast implant-associated anaplastic large cell lymphoma.

Implications:

  • This case suggests a potential causal link between silicone implants and angiosarcoma.
  • Cytological assessment of periprosthetic fluid is vital for diagnosing implant-associated malignancies.
  • Cell blocks and immunohistochemistry are essential tools in diagnosis.